Michael Benkowitz, PRESIDENT AND COO at UNITED THERAPEUTICS Corp (UTHR), sold 33,000 shares at $473.66 ($15.6M) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Scheduled sale ($15.6M) by PRESIDENT AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $473.66 | 2,625 | $1.2M | 8.0% |
| 2 | $473.66 | 2,625 | $1.2M | 8.0% |
| 3 | $473.66 | 7,875 | $3.7M | 23.9% |
| 4 | $473.66 | 7,875 | $3.7M | 23.9% |
| 5 | $473.66 | 12,000 | $5.7M | 36.4% |
| Total | $473.66 avg | 33,000 |
| $15.6M |
| 100% |
| Filing → |
| UTHR | SELL | 2026-02-10 | $21.4M | — | Filing → |
| UTHR | SELL | 2026-02-03 | $21.2M | — | Filing → |
| UTHR | SELL | 2026-01-28 | $13.5M | — | Filing → |